Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Iberis Amara Seed is a non-standardized plant allergenic extract used primarily in allergy diagnostics and as a component in herbal treatments for gastrointestinal disorders. It belongs to the Brassicaceae family and contains bioactive glucosinolates and flavonoids.
Name
Iberis Amara Seed
Raw Name
IBERIS AMARA SEED
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
8
Variant Count
9
Last Verified
February 17, 2026
About Iberis Amara Seed
Iberis Amara Seed is a non-standardized plant allergenic extract used primarily in allergy diagnostics and as a component in herbal treatments for gastrointestinal disorders. It belongs to the Brassicaceae family and contains bioactive glucosinolates and flavonoids.
Detailed information about Iberis Amara Seed
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Iberis Amara Seed.
Iberis Amara Seed, derived from the plant commonly known as Bitter Candytuft, is a botanical substance classified by the FDA as a Non-Standardized Plant Allergenic Extract [EPC] and a Non-Standardized Food Allergenic Extract [EPC]. This classification indicates that the substance is used clinically to diagnose or treat hypersensitivity (allergic) reactions to the plant or its related components. Beyond its role in allergology, Iberis Amara Seed has a long-standing history in European phytomedicine, particularly for its prokinetic (motility-enhancing) effects on the gastrointestinal tract. It is a primary constituent in multi-herb preparations used to treat functional dyspepsia (chronic indigestion) and irritable bowel syndrome (IBS).
Pharmacologically, Iberis Amara Seed belongs to the class of drugs known as allergenic extracts when used for testing, and it is considered a botanical therapeutic when used for digestive health. The seed contains a complex matrix of bioactive compounds, including glucosinolates (specifically glucoiberin), cucurbitacins, and flavonoids (such as kaempferol and quercetin). These components work synergistically to modulate smooth muscle tone in the gut. While the FDA regulates it as an allergenic extract for diagnostic purposes, its use in oral supplements for digestive health is often governed by different regulatory frameworks depending on the country, such as the EMA (European Medicines Agency) in Europe.
In the context of its classification as an allergenic extract, Iberis Amara Seed works by eliciting a localized or systemic immunological response. When applied via a skin prick test (SPT), the proteins and allergens within the extract interact with IgE antibodies bound to mast cells in the skin. If the patient is sensitized, this interaction triggers the release of histamine and other inflammatory mediators, resulting in a 'wheal and flare' reaction (a raised bump and redness). This allows healthcare providers to confirm a clinical diagnosis of plant-based allergies.
At the molecular level regarding gastrointestinal function, Iberis Amara Seed exhibits a dual-action mechanism on the smooth muscles of the digestive tract. Research suggests it acts as a prokinetic in the proximal (upper) stomach by increasing the basal tone and the contraction of the gastric antrum (the lower part of the stomach). Conversely, it has spasmolytic (muscle-relaxing) properties in the distal (lower) segments of the gastrointestinal tract, such as the small intestine. This 'dual action' is thought to be mediated through the modulation of muscarinic and serotonergic (5-HT) receptors. Specifically, it may act as an antagonist at 5-HT3 receptors and an agonist at 5-HT4 receptors, which are critical pathways for regulating gut motility and sensation. Additionally, the flavonoids in the seed provide anti-inflammatory and antioxidant effects by inhibiting the production of leukotrienes and other pro-inflammatory cytokines.
Iberis Amara Seed is primarily used for the following indications:
Iberis Amara Seed is available in several specialized forms:
> Important: Only your healthcare provider can determine if Iberis Amara Seed is right for your specific condition.
The dosage of Iberis Amara Seed depends entirely on the clinical application (diagnostic vs. therapeutic) and the specific formulation used. Because it is a non-standardized extract, dosing is often expressed in terms of volume or weight of the plant material.
There are no specific dosage adjustments provided by manufacturers for patients with kidney disease. However, since metabolites are excreted renally, patients with end-stage renal disease (ESRD) should be monitored for any unusual systemic accumulation.
Caution is advised in patients with pre-existing liver disease. While Iberis Amara Seed itself is not a known potent hepatotoxin, some combination products containing it have been associated with rare reports of liver enzyme elevations. Patients with severe hepatic impairment should consult their physician before use.
No specific age-related dose adjustments are required. However, elderly patients may be more sensitive to the prokinetic effects and should be monitored for changes in bowel frequency or potential interactions with other medications for chronic conditions.
If you miss a dose of the oral extract, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this may increase the risk of gastrointestinal upset.
Signs of an oral overdose may include severe nausea, vomiting, diarrhea, or abdominal cramping. In the case of an allergenic extract overdose (e.g., accidental injection or excessive skin application), signs of a systemic allergic reaction (anaphylaxis) may occur, including hives, swelling of the throat, difficulty breathing, and low blood pressure.
In the event of a suspected overdose or severe reaction, seek emergency medical attention immediately or contact a poison control center.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
When used for skin testing, the most common side effect is a localized reaction at the site of application. This includes:
When taken orally for digestive issues, common side effects are generally mild and include:
> Warning: Stop taking Iberis Amara Seed and call your doctor immediately if you experience any of these.
There is limited data on the long-term use of Iberis Amara Seed as a standalone agent. When used in combination products for functional dyspepsia, studies lasting up to 12 weeks have shown a favorable safety profile. However, chronic use (years) has not been extensively studied in controlled clinical trials. Potential long-term concerns could include the development of a secondary sensitivity (allergy) to the plant proteins or changes in the gut microbiome, although these remain theoretical. Regular monitoring by a healthcare provider is recommended for those using the product for more than three months.
No FDA black box warnings currently exist for Iberis Amara Seed. However, as with all allergenic extracts, there is an inherent risk of severe systemic reactions. Healthcare providers are advised to observe patients for at least 30 minutes following skin testing or immunotherapy injections to ensure safety.
Report any unusual symptoms to your healthcare provider.
Iberis Amara Seed must be used with caution in individuals with a known history of severe allergies, particularly to plants in the Brassicaceae (mustard) family. This includes common vegetables like broccoli, cabbage, and mustard greens. Because this is a non-standardized extract, the concentration of specific allergens can vary between batches, which may lead to inconsistent diagnostic results or unexpected reactions.
No FDA black box warnings for Iberis Amara Seed. While some allergenic extracts carry a boxed warning for the risk of anaphylaxis, this is typically reserved for standardized extracts or those used in high-dose immunotherapy. Nevertheless, the risk of a systemic reaction is always present with any allergen exposure.
Iberis Amara Seed generally does not cause sedation or cognitive impairment. However, if a patient experiences dizziness or a systemic allergic reaction, they should refrain from driving or operating heavy machinery until the symptoms have completely resolved and they have been cleared by a medical professional.
There are no known direct interactions between Iberis Amara Seed and alcohol. However, many liquid extracts of Iberis Amara contain a small percentage of ethanol (alcohol) as a preservative or solvent. Patients with alcohol use disorder or those taking medications like disulfiram should be aware of this alcohol content. Furthermore, alcohol can irritate the stomach lining and may worsen the symptoms of functional dyspepsia or IBS that the seed is intended to treat.
There is no known withdrawal syndrome associated with stopping Iberis Amara Seed. Patients can typically discontinue the product without tapering. However, if being used for chronic digestive issues, symptoms may return once the prokinetic and spasmolytic support is removed.
> Important: Discuss all your medical conditions with your healthcare provider before starting Iberis Amara Seed.
For each major interaction, the mechanism is usually related to the pharmacodynamic suppression of the histamine response (in the case of allergy testing) or additive effects on the muscarinic/serotonergic receptors in the gut. Management typically involves the temporary discontinuation of interfering medications or dose adjustment of the botanical extract.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Iberis Amara Seed must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a healthcare provider include:
Patients who are allergic to other members of the Brassicaceae family (also known as Cruciferae) may exhibit cross-sensitivity to Iberis Amara Seed. This family includes:
If you have a known allergy to mustard, you must inform your allergist before undergoing testing with Iberis Amara Seed.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Iberis Amara Seed.
Iberis Amara Seed is generally categorized as a substance where safety has not been established during pregnancy. There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have not been conducted for this specific non-standardized extract. In traditional use, bitter herbs are sometimes avoided during pregnancy due to the theoretical risk of stimulating uterine contractions. Therefore, Iberis Amara Seed should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus, and only under the direct supervision of an obstetrician.
It is not known whether the bioactive components of Iberis Amara Seed, such as glucoiberin or its metabolites, are excreted in human milk. Because many drugs and botanical compounds are secreted into breast milk, caution should be exercised. The primary concern would be the potential for the infant to experience gastrointestinal changes (such as colic or diarrhea) or to develop a sensitivity to the plant proteins. Most healthcare providers recommend avoiding the use of non-essential botanical extracts while breastfeeding unless the clinical need is significant.
Iberis Amara Seed is frequently used in pediatric populations for the diagnosis of allergies. In the context of oral use for digestive issues, some standardized combination products have been studied in children as young as 3 years old. However, the use of non-standardized extracts in children should be approached with caution. Dosing must be carefully adjusted based on age or weight, and children should be monitored closely for any signs of allergic reactions or excessive bowel stimulation.
Clinical studies of products containing Iberis Amara Seed have included elderly patients, and no overall differences in safety or effectiveness have been observed compared to younger subjects. However, the elderly are more likely to have co-existing conditions, such as reduced renal function or polypharmacy (taking multiple medications). Healthcare providers should consider the alcohol content of liquid extracts when prescribing to elderly patients who may be taking medications that interact with ethanol.
Specific data regarding the use of Iberis Amara Seed in patients with renal impairment are unavailable. Since the metabolites of the glucosinolates and flavonoids found in the seed are primarily excreted via the kidneys, there is a theoretical risk of accumulation in patients with a significantly reduced Glomerular Filtration Rate (GFR). Dose adjustments are not standardized, but monitoring for increased side effects is prudent.
As previously mentioned, there have been rare, isolated reports of liver dysfunction associated with the use of herbal products containing Iberis Amara. While a direct causal link to the Iberis Amara Seed itself is not firmly established, patients with Child-Pugh Class B or C hepatic impairment should be monitored with regular liver function tests if they are using this substance orally for an extended period.
> Important: Special populations require individualized medical assessment.
Iberis Amara Seed acts through a multi-target pharmacological approach. In the gastrointestinal tract, its prokinetic effect is primarily attributed to its ability to increase the tone of the gastric antrum and stimulate the contraction of smooth muscle cells. This is thought to be mediated by the modulation of muscarinic (M3) receptors and serotonergic (5-HT4) receptors, which are responsible for initiating the peristaltic reflex. Simultaneously, the extract exhibits spasmolytic effects in the small intestine, likely through the inhibition of calcium channels or the modulation of 5-HT3 receptors, which helps to relieve cramping and pain.
In the context of its use as an allergenic extract, the mechanism involves the cross-linking of IgE antibodies on the surface of mast cells and basophils. This triggers a signal transduction cascade involving tyrosine kinases, leading to the degranulation of the cells and the release of pre-formed mediators like histamine, proteoglycans, and serine proteases, as well as the de novo synthesis of leukotrienes and prostaglandins.
The pharmacodynamics of Iberis Amara Seed are characterized by a relatively rapid onset of action in the gut. When taken as a liquid extract, patients often report a reduction in bloating or fullness within 15 to 30 minutes. The duration of effect is typically 4 to 6 hours, which necessitates three-times-daily dosing for chronic conditions. No significant development of tolerance has been reported in clinical trials lasting up to 12 weeks.
| Parameter | Value |
|---|---|
| Bioavailability | Variable (Botanical Mixture) |
| Protein Binding | Not Fully Characterized |
| Half-life | ~2-4 hours (for marker compounds) |
| Tmax | 1-2 hours (Oral) |
| Metabolism | Hepatic (Phase II Conjugation) |
| Excretion | Renal (>60%), Fecal (<40%) |
Iberis Amara Seed is classified as a Non-Standardized Plant Allergenic Extract. In the therapeutic context, it is often grouped with other gastrointestinal prokinetics and spasmolytics. It is unique in its 'dual-action' profile, setting it apart from purely prokinetic drugs like metoclopramide or purely spasmolytic drugs like hyoscyamine.
Medications containing this ingredient
Common questions about Iberis Amara Seed
Iberis Amara Seed is primarily used in two ways: as a diagnostic tool for allergy testing and as a natural treatment for digestive disorders. In allergy clinics, it is used as a skin prick extract to identify if a person is allergic to the Bitter Candytuft plant or related species. In gastroenterology, it is a key ingredient in herbal medicines used to treat functional dyspepsia and irritable bowel syndrome (IBS). It works by helping the stomach move food along more efficiently while also relaxing the intestines to reduce cramping. You should only use it for these purposes under the guidance of a healthcare professional.
The side effects depend on how the extract is used. When applied to the skin for allergy testing, the most common reactions are localized itching, redness, and a small raised bump (wheal) at the test site. When taken orally as a liquid or capsule, some people may experience mild stomach upset, nausea, or a slight change in bowel habits like diarrhea. These symptoms are usually temporary and resolve on their own. However, if you experience a severe rash or difficulty breathing, you must seek medical help immediately.
There is no direct evidence that alcohol interacts dangerously with Iberis Amara Seed itself. However, many liquid forms of this extract contain a small amount of alcohol as a preservative, which might be a concern for some individuals. Additionally, alcohol can worsen the symptoms of indigestion and IBS, which are the very conditions the seed is often used to treat. It is generally best to limit alcohol consumption when managing gastrointestinal issues. Always consult your doctor if you have concerns about alcohol use and your medications.
The safety of Iberis Amara Seed during pregnancy has not been clearly established through clinical trials. Because it is a botanical extract with complex active ingredients, most doctors recommend avoiding its use during pregnancy unless it is absolutely necessary. There is a theoretical concern that bitter herbs could affect the uterus, although this has not been proven for Iberis Amara. If you are pregnant or planning to become pregnant, you should discuss the risks and benefits with your obstetrician before using any product containing this ingredient.
When used for allergy testing, the results are visible very quickly, usually within 15 to 20 minutes after the skin prick. For digestive symptoms like bloating and gas, many patients notice an improvement within 15 to 30 minutes of taking an oral dose. However, for chronic conditions like functional dyspepsia or IBS, it may take several days of consistent use (three times a day) to feel the full therapeutic benefits. If your symptoms do not improve after two weeks of use, you should consult your healthcare provider for further evaluation.
Yes, you can generally stop taking Iberis Amara Seed suddenly without experiencing withdrawal symptoms. It is not a habit-forming substance, and it does not require a tapering period. However, if you were using it to manage chronic digestive issues, you may find that your symptoms return once you stop taking the extract. It is always a good idea to inform your doctor if you decide to stop a treatment, especially if it was part of a long-term management plan for your health.
If you miss a dose of the oral extract, take it as soon as you remember. However, if it is almost time for your next scheduled dose, it is better to skip the missed dose entirely and continue with your regular schedule. You should never take two doses at once to make up for a missed one, as this could lead to stomach irritation or nausea. Consistency is key for managing digestive symptoms, so try to take your doses at the same time each day, preferably before or with your meals.
There is no clinical evidence to suggest that Iberis Amara Seed causes weight gain. The extract does not contain significant calories, nor does it affect metabolic hormones or appetite in a way that would lead to an increase in body fat. In fact, by improving digestion and reducing bloating, some patients may feel more comfortable and less 'heavy.' If you notice any unexpected weight changes while taking this or any other supplement, you should discuss them with your doctor to identify the underlying cause.
Iberis Amara Seed can interact with certain medications, particularly those used for allergies. Antihistamines, for example, can interfere with the accuracy of allergy skin tests using this extract. There is also a theoretical risk when taken with other drugs that affect gut motility. Because it is often part of a multi-herb mixture, the potential for interactions may be higher than with a single-ingredient product. Always provide your healthcare provider with a complete list of all the medications and supplements you are currently taking.
Because Iberis Amara Seed is a botanical extract and not a synthetic drug, the concept of 'generic' is slightly different. It is available under various brand names and as a component of several different herbal formulations. While there may be 'store-brand' versions of certain herbal mixtures, the quality and concentration of the Iberis Amara extract can vary significantly between products. It is important to choose a high-quality, reputable brand that has been clinically studied or recommended by your healthcare professional to ensure you are getting a consistent dose.